Autologous Tumor Infiltrating Lymphocytes LN-145
Sponsors
M.D. Anderson Cancer Center, Roswell Park Cancer Institute
Conditions
Bone SarcomaDedifferentiated ChondrosarcomaGiant Cell Tumor of BoneMalignancy in Giant Cell Tumor of BoneMalignant Solid NeoplasmMetastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis Urothelial CarcinomaMetastatic Ureter Urothelial Carcinoma
Phase 2
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
Active, not recruitingNCT03449108
Start: 2018-04-27End: 2027-04-30Updated: 2026-05-22
Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy
WithdrawnNCT03935347
Start: 2019-06-20End: 2023-05-01Updated: 2020-01-02